Ureteric JJ stents are in serted in nu mer ous patients as a rou tine pro ce dure. Nev er the less, the ideal JJ stent that does not cause any lower uri nary tract symp toms has not been de vel oped yet. Even spe cial val i dated question naires have been used for the as sess ment of JJ stent-re lated symtoms. For the man age ment of such symtoms usu ally al pha-blockers are ad minis tered. Also, stud ies have ex am ined the ef fi cacy and safety of anticholinergics and cal cium chan nel blockers. In this ar ti cle we re view the lit er a ture upon the man age ment of JJ stent-re lated symp toms.
l though ureteric JJ stents have been widely used in Urol ogy for many de cades and their place ment is con sid ered a rou tine pro ce dure, they are as so ci ated with sig nif i cant mor bid ity and a neg a tive im pact on pa tient's qual ity of life (QoL) 1 . Fur ther more there is no con sen sus re gard ing JJ stent place ment af ter ureteroscopic lithotripsy or whether it is needed be fore extracorporeal shock wave lithotripsy (ESWL) 2 . Joshi et al. 3 rec og nized pa tient mor bid ity as so ci ated with ureteral JJ stents as a sig nif icant health prob lem and de vel oped a val i dated ques tionnaire (USSQ: Ureteric Symp tom Score Ques tion naire). USSQ has been used to de ter mine whether novel stent de signs, shapes, ma te rial or drug coat ings con fer any improve ment in JJ stent re lated symp toms and/or if med i cations de crease JJ stent re lated mor bid ity.
Sev eral phar ma ceu ti cal stud ies [3] [4] [5] [6] [7] [8] [9] [10] [11] and meta-anal y ses 4, 5 dem on strated a con sis tent ben e fi cial ef fect of al phablockers in pa tients with in dwell ing ureteral JJ stents. The ad min is tra tion of a se lec tive al pha-blocker, such as alfuzosin or tamsulosin, im proved stent re lated uri nary symp toms, es pe cially pain. In ad di tion, sex ual func tion and gen eral health were better pre served. Deliveliotis et al. 4 dem on strated that al pha-blockers had a pos i tive impact on JJ stent re lated symp toms. In their ran dom ized pro spec tive study they com pared alfuzosin ver sus placebo in af fect ing symp toms and QoL in pa tients with indwell ing ureteral JJ stents. The au thors ad min is tered the USSQ four weeks af ter stent in ser tion and con cluded that alfuzosin im proved JJ stent re lated uri nary symp toms and pain, while sex ual func tion and gen eral health were better pre served. In a pro spec tive, ran dom ized, pla cebo con trolled study of 55 pa tients with in dwell ing ureteral stents af ter ureteroscopy, Beddingfield et al. 6 re ported that alfuzosin mark edly de creased the pain as so ci ated with ureteral stents but had lit tle ef fect on uri nary symptoms in gen eral. They ad min is tered the USSQ pre op er atively and three days af ter the pro ce dure, which may have been too early. Damiano et al. 10 per formed a prospec tive ran dom ized study com par ing the ef fi cacy of tamsulosin ver sus pla cebo for JJ stent re lated symp toms in 75 pa tients. The au thors con cluded that tamsulosin had a pos i tive ef fect on stent re lated uri nary symp toms and QoL. Wang et al. 7 per formed a pro spec tive ran dom ized trial com par ing the ef fect of tamsulosin vs pla cebo on stent re lated symp toms in 154 pa tients us ing the USSQ and the In ter na tional Pros tate Symp tom Score (IPSS). They re ported sig nif i cant dif fer ences in the main score in dex of uri nary symp toms, body pain and gen eral health in fa vor of tamsulosin. Navanimitkul et al.
11 as sessed the ef fi cacy of tamsulosin in im prov ing stent-re lated symptoms and qual ity of life in pa tients with in dwell ing JJ ureteral stents af ter ureteroscopy, percutaneous nephrolithotomy or bal loon di la ta tion. They used the IPSS and SF-36 ques tion naires at 2 and 4 weeks post op er a tively. The IPSS and SF-36 scores were sig nif i cantly better in tamsulosin group fa vor ing its ad min is tra tion. Tamsulosin im proved both uri nary symp toms and qual ity of life without caus ing se ri ous side-ef fects.
Along with the abovementioned stud ies con cern ing alpha-blockers, sim i lar stud ies were per formed with drugs such as anticholinergics in the treat ment of stent re lated symp toms. Park et al. 5 per formed a pro spec tive ran domized study to eval u ate the ef fects of tolterodine and alfuzosin for the treat ment of JJ stent-re lated lower uri - 12 con ducted a prospec tive, ran dom ized dou ble-blind, pla cebo con trolled trial com par ing oxybutynin with phenazopyridine and pla cebo for the man age ment of JJ stent re lated symp toms in 60 pa tients. They used a non-val i dated symp tom question naire and a vi sual an a log pain (VAS) scale to measure JJ stent re lated symp toms. The au thors con cluded that there were no sta tis ti cal sig nif i cant dif fer ences between the med i ca tions and pla cebo.
Al though the abovementioned stud ies were not uniformly de signed and in many cases un der pow ered the pos i tive ef fect of a-blockers was far from any doubt, while the use of anticholinergics or an al ge sics needs further eval u a tion in pro spec tive stud ies. Most stud ies did not re ported all as pects of USSQ and did not com plete it reg u larly like the study by Dellis et al. 9 , where USSQ was com pleted the 1st and 4th week with the JJ stent in situ and 4 weeks af ter its re moval.
The pathophysiology of stent re lated pain may be related to ir ri ta tion of the trigone, smooth mus cle spasm and/or in flam ma tion in the ureter and blad der. The big ger ef fect of aá -blockers on pain more than on uri nary symptoms sug gest that smooth mus cle spasm in the ureter and blad der has a sig nif i cant role. Fur ther com par a tive studies with antimuscarinics, ste roids and cal cium chan nel blockers are needed as well as the use of val i dated question naires. Lastly, com par a tive stud ies be tween con ventional JJ stent and ureteric metal stents would be very use ful.
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SUMMARY
Ureteralni JJ stentovi se postavljaju rutinski kod velikog broja bolesnika. I pored toga idealni JJ stentovi koji ne izazivaju simptome donjeg urinarnog trakta još uvek nisu razvijeni. Postoje ~ak i specijalizovani upitnici za procenu JJ sondama izazvanih simptoma. U tretmanu ovih simptoma uglavnom se koriste alfa blokatori. Istraivanja su se takodje bavila i uticajem antiholinergika i blokatora kalcijumskih kanala na ove simptome. U našem radu je pregledno predstavljena literatura o tretmanu simptoma donjeg urinarnog trakta izazvanih JJ stentovima.
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